2015
DOI: 10.1016/j.yjmcc.2015.05.003
|View full text |Cite
|
Sign up to set email alerts
|

Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories

Abstract: Cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSCs) are being increasingly used to model human heart diseases. hiPSC-CMs generated by earlier aggregation-based methods (i.e., embryoid body) often lack functional sarcoplasmic reticulum (SR) Ca stores characteristic of mature mammalian CMs. Newer monolayer-based cardiac differentiation methods (i.e., Matrigel sandwich or small molecule-based differentiation) produce hiPSC-CMs of high purity and yield, but their Ca handling has not bee… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
137
0
4

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 145 publications
(151 citation statements)
references
References 43 publications
10
137
0
4
Order By: Relevance
“…This particularly impacts I Ks and I K1 , whose contribution is essential for a correct prediction of drug effects. Only few attempts have been made to promote phenotypic uniformity in hiPSC‐CMs (Hwang et al , 2015a; Zhu et al , 2016), and we believe that the reproducibility of outcomes would benefit from standardized conditions to provide better input for computational models. On the other hand, as highlighted by Rodriguez et al , the cross‐institutional limitations of accessing in vitro propriety data profoundly slows the development of comprehensive computational models (Rodríguez et al , 2015).…”
Section: Assays and Readoutsmentioning
confidence: 99%
See 1 more Smart Citation
“…This particularly impacts I Ks and I K1 , whose contribution is essential for a correct prediction of drug effects. Only few attempts have been made to promote phenotypic uniformity in hiPSC‐CMs (Hwang et al , 2015a; Zhu et al , 2016), and we believe that the reproducibility of outcomes would benefit from standardized conditions to provide better input for computational models. On the other hand, as highlighted by Rodriguez et al , the cross‐institutional limitations of accessing in vitro propriety data profoundly slows the development of comprehensive computational models (Rodríguez et al , 2015).…”
Section: Assays and Readoutsmentioning
confidence: 99%
“…Even though Ca 2 + ‐handling features appear conserved in independent hiPSC‐CM cultures from different research groups (Hwang et al , 2015a, 2015b; Kane and Terracciano, 2015), heterogeneity has been widely observed in other electrophysiological properties such as the APD (Figure 3), upstroke velocity and current densities (Hoekstra et al , 2012). Inconsistent results on the mechanism of hiPSC‐CM automaticity have also been noted: Kim et al reported a Ca 2 + clock mechanism, consistent with ivabradine having no effect on beating frequency (Kim et al , 2015).…”
Section: Limitations In Applicability Of Hipsc‐cm To Large‐scale Drugmentioning
confidence: 99%
“…Calcium transport by SERCA was found to be similar in stem cells-cardiac myocyte lines [5] . Mesenchymal stem cells (MSCs) are widely used for both allogeneic and autologous transplantations.…”
Section: +mentioning
confidence: 91%
“…162, 163 The gene expression profiles, especially those of contractile proteins, simulate fetal cardiomyocytes. 164 Furthermore, the hiPSC-CMs have poorly developed SR and altered calcium handling at early stages of differentiation, 165 nonexistent t-tubules, 166 automaticity, 167 and preference for glucose metabolism over fatty acid metabolism, 168 which are all consistent with immature phenotypes. Although various maturation techniques (e.g., electromechanical stimulation, 153, 169 overexpression of cardiac genes 101 or miR-499, 170 exposure to fatty acid supplementation, 90 and incorporation of cardiomyocytes into 3D tissue constructs 105 ) have all been tried with varying degrees of success, it is unclear whether the most mature hiPSC-CMs developed in an artificial cell culture environment can achieve the same level of maturity as adult cardiomyocytes in vivo .…”
Section: Challenges and Future Directionsmentioning
confidence: 92%